Disclosed is an immunogenic composition comprising: (a) a polynucleotide adjuvant comprising: a polyriboinosinic-polyribocytidylic acid (PIC), at least one antibiotic, and at least one positive ion and (b) at least one antigen wherein the composition is formulated for mucosal administration.